RARE vs TPTA · rev $350.0M vs rev $49.7M
Ultragenyx (RARE) versus Terra Property Trust, Inc. 6.00% (TPTA) — a side-by-side from cached financials, not a winner call.
Ultragenyx (RARE) is a biotechnology company listed on US.
Terra Property Trust, Inc. 6.00% (TPTA) common stock listed on NYSE.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
Latest reported TPTA revenue for 2024-12-31 was $49.7M. Net income was -$37.2M. Revenue was down 26.8% from 2023-12-31 to 2024-12-31. TPTA currently screens at market cap $0.
RARE currently screens at market cap $2.79B. TPTA currently screens at market cap $0.
Not investment advice. Open the RARE and TPTA stock pages for the full models.
Not investment advice.